Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat

被引:37
|
作者
Woodhams, S. G. [1 ]
Wong, A. [2 ]
Barrett, D. A. [2 ]
Bennett, A. J. [1 ]
Chapman, V. [1 ,3 ]
Alexander, S. P. H. [1 ]
机构
[1] Univ Nottingham, Sch Med, Sch Biomed Sci, Nottingham NG7 2UH, England
[2] Univ Nottingham, Sch Pharm, Ctr Analyt Biosci, Nottingham NG7 2UH, England
[3] Univ Nottingham, Arthrit Res UK Pain Ctr, Nottingham NG7 2UH, England
基金
英国医学研究理事会;
关键词
2-arachidonoylglycerol; endocannabinoid system; JZL184; monoacylglycerol lipase; pain; CB1; receptor; ACID AMIDE HYDROLASE; DORSAL-HORN NEURONS; RECEPTOR; BRAIN; ENDOCANNABINOIDS; ACTIVATION; 2-ARACHIDONOYLGLYCEROL; HYDROLYSIS; RESPONSES; CANNABINOIDS;
D O I
10.1111/j.1476-5381.2012.02179.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Purpose The cannabinoid receptor-mediated analgesic effects of 2-arachidonoylglycerol (2-AG) are limited by monoacylglycerol lipase (MAGL). 4-nitrophenyl 4-[bis (1,3-benzodioxol-5-yl) (hydroxy) methyl] piperidine-1-carboxylate (JZL184) is a potent inhibitor of MAGL in the mouse, though potency is reportedly reduced in the rat. Here we have assessed the effects of spinal inhibition of MAGL with JZL184 on nociceptive processing in rats. Experimental Approach In vivo spinal electrophysiological assays in anaesthetized rats were used to determine the effects of spinal administration of JZL184 on spinal nociceptive processing in the presence and absence of hindpaw inflammation. Contributions of CB1 receptors to these effects was assessed with AM251. Inhibition of 2-oleoylglycerol hydrolytic activity and alterations of 2-AG in the spinal cord after JZL 184 were also assessed. Key Results Spinal JZL184 dose-dependently inhibited mechanically evoked responses of wide dynamic range (WDR) neurones in naive anaesthetized rats, in part via the CB1 receptor. A single spinal administration of JZL184 abolished inflammation-induced expansion of the receptive fields of spinal WDR neurones. However, neither spinal nor systemic JZL184 altered levels of 2-AG, or 2-oleoylglycerol hydrolytic activity in the spinal cord, although JZL184 displayed robust inhibition of MAGL when incubated with spinal cord tissue in vitro. Conclusions and Implications JZL184 exerted robust anti-nociceptive effects at the level of the spinal cord in vivo and inhibited rat spinal cord MAGL activity in vitro. The discordance between in vivo and in vitro assays suggests that localized sites of action of JZL184 produce these profound functional inhibitory effects. Linked Articles This article is part of a themed section on Cannabinoids. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.167.issue-8
引用
收藏
页码:1609 / 1619
页数:11
相关论文
共 8 条
  • [1] Anti-invasive and antimetastatic effects of the monoacylglycerol lipase inhibitor JZL184 on human lung cancer cells
    Ramer, R.
    Prueser, J. L.
    Wittig, F.
    Igor, I.
    Merkord, J.
    Hinz, B.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (SUPPL 1) : 29 - 30
  • [2] Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice
    Marino, Silvia
    de Ridder, Danielle
    Bishop, Ryan T.
    Renema, Nathalie
    Ponzetti, Marco
    Sophocleous, Antonia
    Capulli, Mattia
    Aljeffery, Abdullah
    Carrasco, Giovana
    Gens, Marianela Dalghi
    Khogeer, Asim
    Ralston, Stuart H.
    Gertsch, Juerg
    Lamoureux, Francois
    Heymann, Dominique
    Rucci, Nadia
    Idris, Aymen I.
    [J]. EBIOMEDICINE, 2019, 44 : 452 - 466
  • [3] The monoacylglycerol lipase inhibitor, JZL184, has comparable effects to therapeutic hypothermia, attenuating global cerebral injury in a rat model of cardiac arrest
    Xu, Jing
    Zheng, Guanghui
    Hu, Juntao
    Ge, Weiwei
    Bradley, Jennifer L.
    Ornato, Joseph P.
    Tang, Wanchun
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
  • [4] Effects of the monoacylglycerol lipase inhibitor JZL184 on chickens infected with avian pathogenic Escherichia coli 078: A preliminary pharmacokinetic and infection study
    Ho, Cherry P.
    Borazjani, Abdolsamad
    Ross, Matthew K.
    Wang, Chinling
    [J]. CANADIAN JOURNAL OF VETERINARY RESEARCH-REVUE CANADIENNE DE RECHERCHE VETERINAIRE, 2020, 84 (03): : 189 - 197
  • [5] Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1-Mediated Antinociceptive and Gastroprotective Effects
    Kinsey, Steven G.
    Wise, Laura E.
    Ramesh, Divya
    Abdullah, Rehab
    Selley, Dana E.
    Cravatt, Benjamin F.
    Lichtman, Aron H.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 345 (03): : 492 - 501
  • [6] Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats
    Sciolino, Natale R.
    Zhou, Wenyi
    Hohmann, Andrea G.
    [J]. PHARMACOLOGICAL RESEARCH, 2011, 64 (03) : 226 - 234
  • [7] The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action
    Kerr, D. M.
    Harhen, B.
    Okine, B. N.
    Egan, L. J.
    Finn, D. P.
    Roche, M.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (04) : 808 - 819
  • [8] The monoacylglycerol lipase inhibitor JZL184 exhibits antiangiogenic effects on endothelial cells through inhibition of VEGF expression in hypoxic lung cancer cells
    Wittig, F.
    Pannenberg, L.
    Schwarz, R.
    Bekeschus, S.
    Ramer, R.
    Hinz, B.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S23 - S23